Abstract:Pathological cardiac hypertrophy could lead to heart failure and sudden cardiac death. Our previous study demonstrated that Class I PI3‐kinase (PI3KC1) contributes to the development of cardiac hypertrophy by elevating intracellular reactive oxygen species (ROS) levels. In the current study, we evaluated the role of Class III PI3‐kinase (PI3KC3) in Ang II‐induced cardiac hypertrophy. Treatment of cultured cardiomyocytes with Ang II (10−6 M) significantly increased the cellular surface area, which was measured under a fluorescence microscope after staining with anti‐alpha‐sarcomeric actin antibodies. In cardiomyocytes, Ang II (10−9‐10−5 M) induced a dose‐dependent activation of PI3KC3, detected using an ELISA kit. More interestingly, Ang II‐induced cardiac hypertrophy was dramatically exacerbated by co‐treatment with 3‐Methyladenine (3‐MA, 10−6 M), a PI3KC3 inhibitor, suggesting that activation of PI3KC3 may play a protective role in Ang II‐induced cardiac hypertrophy. To identify the intracellular signaling pathway involved in the PI3KC3‐mediated protective effect, mitochondrial ROS was measured using MitoSOX in cardiomyocytes treated with control, Ang II (10−6 M), Ang II plus 3‐MA (10−6 M), and 3‐MA alone. The results demonstrated that Ang II treatment significantly increased mitochondrial ROS production and that Ang II‐induced increases in ROS generation were potentiated by co‐treatment with 3‐MA. It is well known that the major intracellular source of ROS is the damaged mitochondria, which is scavenged by autophagy (also called mitophagy) in cardiomyocytes. Thus, we measured autophagy activity by detection of autophagosomes using staining method with MAP‐LC3 antibodies in cardiomyocytes treated with Ang II. Treatment of cardiomyocytes with Ang II (10−9 to 10−5 M) significantly increased autophagy activity with two phases (increased activity at low doses, decreased activity at high doses, peaked at 10−7 M). More interestingly, Ang II (10−6 M)‐induced increases in autophagy were dramatically attenuated by 3‐MA (10−6 M). Taken together, these data suggest that activation of PI3KCIII has a protective effect on Ang II‐induced hypertrophy by enhancing autophagy activity and decreasing mitochondrial ROS generation in cardiomyocytes.Support or Funding InformationNIH HL143519

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

JAK/STAT3 signaling pathway is involved in α1-AR-mediated cardiac hypertrophy

Increased Myocardial Stiffness Activates Cardiac Microvascular Endothelial Cell Via VEGF Paracrine Signaling in Cardiac Hypertrophy

Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling

The gp130/STAT3 signaling pathway mediates β-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes

Tumor Necrosis Factor Receptor-Associated Factor 3 is A Positive Regulator of Pathological Cardiac Hypertrophy

Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells

Β3-Adrenergic Receptor Activation Induces TGFβ1 Expression in Cardiomyocytes Via the PKG/JNK/c-Jun Pathway.

Signal Transducer and Transcriptional Activation 1 Protects Against Pressure Overload‐induced Cardiac Hypertrophy

Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through Β-Arrestin2–dependent Activation of Calmodulin-Dependent Protein Kinase II

ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, And Fibrosis Induced By Pressure Overload

Endothelial MRTF-A Mediates Angiotensin II Induced Cardiac Hypertrophy.

Proteomic Profiling Reveals Comprehensive Insights into Adrenergic Receptor-Mediated Hypertrophy in Neonatal Rat Cardiomyocytes.

Crosstalk Between Signaling Pathways of Adrenoreceptors and Signal Transducers and Activators of Transcription 3 (STAT3) in Heart

Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation.

Upregulation of Nox4 Promotes Angiotensin II-Induced Epidermal Growth Factor ReceptorActivation and Subsequent Cardiac Hypertrophy by Increasing ADAM17 Expression

Src Tyrosine Kinase Promotes Cardiac Remodeling Induced by Chronic Sympathetic Activation.

Class III PI3‐Kinase in Angiotensin II‐Induced Cardiac Hypertrophy

Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy

Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy